Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 96
Titolo Data di pubblicazione Autore(i) File
Identification of the macromolecular complex responsible for PI3Kgamma-dependent regulation of cAMP levels. 2006 PERINO A; GHIGO A; DAMILANO F; HIRSCH E
Isoform Selective Phosphoinositide 3-Kinase gamma and delta Inhibitors and Their Therapeutic Potential 2008 Ghigo A; Hirsch E
Taming the PI3K team to hold inflammation and cancer at bay 2008 Hirsch E; Ciraolo E; Ghigo A; Costa C
Leukocyte and cardiac phosphoinositide 3-kinase γ activity in pressure overload-induced cardiac failure. 2010 Perino A;Ghigo A;Hirsch E
Pulmonary-derived phosphoinositide 3-kinase gamma (PI3Kγ) contributes to ventilator-induced lung injury and edema. 2010 Fanelli V; Puntorieri V; Assenzio B; Martin EL; Elia V; Bosco M; Delsedime L; Del Sorbo L; Ferrari A; Italiano S; Ghigo A; Slutsky AS; Hirsch E; Ranieri VM.
PI3K inhibition in inflammation:Toward tailored therapies for specific diseases 2010 Ghigo A; Damilano F; Braccini L; Hirsch E
Specific PI3K Isoform Modulation in Heart Failure: Lessons from Transgenic Mice. 2011 Ghigo A; Morello F; Perino A; Damilano F; Hirsch E
Integrating Cardiac PIP(3) and cAMP Signaling through a PKA Anchoring Function of p110γ. 2011 Perino A; Ghigo A; Ferrero E; Morello F; Santulli G; Baillie GS; Damilano F; Dunlop AJ; Pawson C; Walser R; Levi R; Altruda F; Silengo L; Langeberg LK; Neubauer G; Heymans S; Lembo G; Wymann MP; Wetzker R; Houslay MD; Iaccarino G; Scott JD; Hirsch E
Distinct Effects of Leukocyte and Cardiac Phosphoinositide 3-Kinase {gamma} Activity in Pressure Overload-Induced Cardiac Failure 2011 Damilano F; Franco I; Perrino C; Schaefer K; Azzolino O; Carnevale D; Cifelli G; Carullo P; Ragona R; Ghigo A; Perino A; Lembo G; Hirsch E
Phosphoinositide 3-kinases in health and disease. 2012 Ghigo A;Morello F;Perino A;Hirsch E
Phosphoinositides and cardiovascular diseases. 2012 Ghigo A;Perino A;Hirsch E
Phosphoinositide 3-kinase γ protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases. 2012 Ghigo A;Perino A;Mehel H;Zahradníková A Jr;Morello F;Leroy J;Nikolaev VO;Damilano F;Cimino J;De Luca E;Richter W;Westenbroek R;Catterall WA;Zhang J;Yan C;Conti M;Gomez AM;Vandecasteele G;Hirsch E;Fischmeister R
Anchoring proteins as regulators of signaling pathways. 2012 Perino A;Ghigo A;Scott JD;Hirsch E
Therapeutic applications of PI3K inhibitors in cardiovascular diseases. 2013 Ghigo A;Morello F;Perino A;Hirsch E
Hemopexin Therapy Improves Cardiovascular Function by Preventing Heme-Induced Endothelial Toxicity in Mouse Models of Hemolytic Diseases 2013 Vinchi F.; De Franceschi L.; Ghigo A.; Townes T.; Cimino J.; Silengo L.; Hirsch E.; Altruda F.; Tolosano E.
NADPH Oxidases in Heart Failure: Poachers or Gamekeepers? 2013 Zhang M;Perino A;Ghigo A;Hirsch E;Shah AM
Ablation of Calcineurin Aβ Reveals Hyperlipidemia and Signaling Cross-talks with Phosphodiesterases. 2013 Suk HY;Zhou C;Yang TT;Zhu H;Yu RY;Olabisi O;Yang X;Brancho D;Kim JY;Scherer PE;Frank PG;Lisanti MP;Calvert JW;Lefer DJ;Molkentin JD;Ghigo A;Hirsch E;Jin J;Chow CW
Myocyte signalling in leucocyte recruitment to the heart. 2014 Ghigo A;Franco I;Morello F;Hirsch E
Combined inhibition of PI3Kβ and PI3Kγ reduces fat mass by enhancing α-MSH-dependent sympathetic drive. 2014 Perino A;Beretta M;Kilić A;Ghigo A;Carnevale D;Repetto IE;Braccini L;Longo D;Liebig-Gonglach M;Zaglia T;Iacobucci R;Mongillo M;Wetzker R;Bauer M;Aime S;Vercelli A;Lembo G;Pfeifer A;Hirsch E
Elastin degradation and ensuing inflammation as emerging keys to atherosclerosis. 2014 Hirsch E;Ghigo A
Mostrati risultati da 1 a 20 di 96
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile